227 related articles for article (PubMed ID: 18515333)
1. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers.
Brand W; van der Wel PA; Rein MJ; Barron D; Williamson G; van Bladeren PJ; Rietjens IM
Drug Metab Dispos; 2008 Sep; 36(9):1794-802. PubMed ID: 18515333
[TBL] [Abstract][Full Text] [Related]
2. The effect of co-administered flavonoids on the metabolism of hesperetin and the disposition of its metabolites in Caco-2 cell monolayers.
Brand W; Padilla B; van Bladeren PJ; Williamson G; Rietjens IM
Mol Nutr Food Res; 2010 Jun; 54(6):851-60. PubMed ID: 20112299
[TBL] [Abstract][Full Text] [Related]
3. Abcg2/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine.
Pan G; Giri N; Elmquist WF
Drug Metab Dispos; 2007 Jul; 35(7):1165-73. PubMed ID: 17437964
[TBL] [Abstract][Full Text] [Related]
4. Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells.
Brand W; Oosterhuis B; Krajcsi P; Barron D; Dionisi F; van Bladeren PJ; Rietjens IM; Williamson G
Biopharm Drug Dispos; 2011 Dec; 32(9):530-5. PubMed ID: 22083890
[TBL] [Abstract][Full Text] [Related]
5. Intestinal ciprofloxacin efflux: the role of breast cancer resistance protein (ABCG2).
Haslam IS; Wright JA; O'Reilly DA; Sherlock DJ; Coleman T; Simmons NL
Drug Metab Dispos; 2011 Dec; 39(12):2321-8. PubMed ID: 21930826
[TBL] [Abstract][Full Text] [Related]
6. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
7. The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.
An G; Gallegos J; Morris ME
Drug Metab Dispos; 2011 Mar; 39(3):426-32. PubMed ID: 21139040
[TBL] [Abstract][Full Text] [Related]
8. Transepithelial transport of hesperetin and hesperidin in intestinal Caco-2 cell monolayers.
Kobayashi S; Tanabe S; Sugiyama M; Konishi Y
Biochim Biophys Acta; 2008 Jan; 1778(1):33-41. PubMed ID: 18021752
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib.
Chen Y; Agarwal S; Shaik NM; Chen C; Yang Z; Elmquist WF
J Pharmacol Exp Ther; 2009 Sep; 330(3):956-63. PubMed ID: 19491323
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse.
Giri N; Shaik N; Pan G; Terasaki T; Mukai C; Kitagaki S; Miyakoshi N; Elmquist WF
Drug Metab Dispos; 2008 Aug; 36(8):1476-84. PubMed ID: 18443033
[TBL] [Abstract][Full Text] [Related]
11. Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells.
Xia CQ; Liu N; Yang D; Miwa G; Gan LS
Drug Metab Dispos; 2005 May; 33(5):637-43. PubMed ID: 15716365
[TBL] [Abstract][Full Text] [Related]
12. Intestinal absorption mechanisms of MTBH, a novel hesperetin derivative, in Caco-2 cells, and potential involvement of monocarboxylate transporter 1 and multidrug resistance protein 2.
Shen C; Chen R; Qian Z; Meng X; Hu T; Li Y; Chen Z; Huang C; Hu C; Li J
Eur J Pharm Sci; 2015 Oct; 78():214-24. PubMed ID: 26231439
[TBL] [Abstract][Full Text] [Related]
13. Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2).
Shen H; Lee FY; Gan J
J Pharmacol Exp Ther; 2011 May; 337(2):423-32. PubMed ID: 21262849
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid can be used as a surrogate to assess brain exposures of breast cancer resistance protein and P-glycoprotein substrates.
Xiao G; Black C; Hetu G; Sands E; Wang J; Caputo R; Rohde E; Gan LS
Drug Metab Dispos; 2012 Apr; 40(4):779-87. PubMed ID: 22266779
[TBL] [Abstract][Full Text] [Related]
15. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
16. Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design.
Giri N; Agarwal S; Shaik N; Pan G; Chen Y; Elmquist WF
Drug Metab Dispos; 2009 Mar; 37(3):560-70. PubMed ID: 19056916
[TBL] [Abstract][Full Text] [Related]
17. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.
Hoque MT; Kis O; De Rosa MF; Bendayan R
Antimicrob Agents Chemother; 2015 May; 59(5):2572-82. PubMed ID: 25691630
[TBL] [Abstract][Full Text] [Related]
18. Silencing the breast cancer resistance protein expression and function in caco-2 cells using lentiviral vector-based short hairpin RNA.
Zhang W; Li J; Allen SM; Weiskircher EA; Huang Y; George RA; Fong RG; Owen A; Hidalgo IJ
Drug Metab Dispos; 2009 Apr; 37(4):737-44. PubMed ID: 19131524
[TBL] [Abstract][Full Text] [Related]
19. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
20. UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.
Jiang W; Xu B; Wu B; Yu R; Hu M
Drug Metab Dispos; 2012 Feb; 40(2):336-45. PubMed ID: 22071170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]